Evidence map›Paper›PMID 24382350›Full record

ArticleThe Journal of clinical investigation2014

Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia.

Ji-Tian Xu, Jian-Yuan Zhao, Xiuli Zhao, Davinna Ligons, Vinod Tiwari, Fidelis E Atianjoh, Chun-Yi Lee, Lingli Liang, Weidong Zang, Dolores Njoku and 3 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. UltramicronizedCurrent neuropharmacology · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Ji-Tian Xu
Jian-Yuan Zhao
Xiuli Zhao
Davinna Ligons
Vinod Tiwari
Fidelis E Atianjoh
Chun-Yi Lee
Lingli Liang
Weidong Zang
Dolores Njoku
Srinivasa N Raja
Myron Yaster
Yuan-Xiang Tao
Johns Hopkins University · USRutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · USZhengzhou University · CN

Funding

The Role of Endothelin-1 in Sickle Cell DiseaseU01HL117684 · NHLBI · AUGUSTA UNIVERSITY · PI KUTLAR, ABDULLAH, MEILER, STEFFEN · 2013 to 2017
$8.1M
INJURY-INDUCES PAIN-- CHEMICAL MODULATION OF NOCICEPTORSR01NS026363 · NINDS · JOHNS HOPKINS UNIVERSITY · PI RAJA, SRINIVASA N. · 1989 to 2021
$6.8M
mTOR, a new target for opioid-induced tolerance and hyperalgesiaR01DA033390 · NIDA · RBHS-NEW JERSEY MEDICAL SCHOOL · PI TAO, YUAN-XIANG · 2013 to 2017
$1.8M
Epigenetic Regulation of Neuropathic Pain: Role of Native Kv1.2 Antisense RNAR01NS072206 · NINDS · RBHS-NEW JERSEY MEDICAL SCHOOL · PI TAO, YUAN-XIANG · 2011 to 2014
$1.4M
NHLBI NIH HHS HL117684NHLBI NIH HHS U01 HL117684NIDA NIH HHS DA033390NIDA NIH HHS R01 DA033390NINDS NIH HHS NS026363NINDS NIH HHS NS072206NINDS NIH HHS R01 NS026363NINDS NIH HHS R01 NS072206PHS HHS 31171070
6 · The paper itself

Abstract

The development of opioid-induced analgesic tolerance and hyperalgesia is a clinical challenge for managing chronic pain. Adaptive changes in protein translation in the nervous system are thought to promote opioid tolerance and hyperalgesia; however, how opioids drive such changes remains elusive. Here, we report that mammalian target of rapamycin (mTOR), which governs most protein translation, was activated in rat spinal dorsal horn neurons after repeated intrathecal morphine injections. Activation was triggered through μ opioid receptor and mediated by intracellular PI3K/Akt. Spinal mTOR inhibition blocked both induction and maintenance of morphine tolerance and hyperalgesia, without affecting basal pain perception or locomotor functions. These effects were attributed to the attenuation of morphine-induced increases in translation initiation activity, nascent protein synthesis, and expression of some known key tolerance-associated proteins, including neuronal NOS (nNOS), in dorsal horn. Moreover, elevating spinal mTOR activity by knocking down the mTOR-negative regulator TSC2 reduced morphine analgesia, produced pain hypersensitivity, and increased spinal nNOS expression. Our findings implicate the μ opioid receptor-triggered PI3K/Akt/mTOR pathway in promoting morphine-induced spinal protein translation changes and associated morphine tolerance and hyperalgesia. These data suggest that mTOR inhibitors could be explored for prevention and/or reduction of opioid tolerance in chronic pain management.

Indexed as

AnimalsCell ProliferationDose-Response Relationship, DrugDrug ToleranceHyperalgesiaInjections, SpinalMaleMechanistic Target of Rapamycin Complex 1MorphineMultiprotein ComplexesNeuronsPainPain ManagementPhosphatidylinositol 3-KinasesRatsRats, Sprague-DawleyMechanistic Target of Rapamycin Complex 1MorphineMultiprotein ComplexesPhosphatidylinositol 3-KinasesReceptors, Opioid, muSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID24382350
PMCPMC3904613
OpenAlexW1988029680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.